Our Take: 2018 MSSP performance data released by CMS

CMS last week released 2018 performance results for its Medicare Shared Savings Program (MSSP). This week we’ll review some top-line results.
Our Take: Quality
A glance at the list below shows that physician-led ACOs also stand out as leaders in quality. We looked at the top five performers on five common quality measures, and 85% of the ACOs were physician-led. Note that despite the improved financial performance of those ACOs taking on downside risk, 72% of the ACOs listed below are Track 1 (no downside risk).
- Managing poorly controlled diabetic population: Billings Clinic, Rio Grande Valley Health Alliance, Village MD New Hampshire ACO, SERPA-ACO (Neb.), and Great Plains Care Organization (Iowa)
- Controlling high blood pressure: Rio Grande Valley Health Alliance, Akira Health of Los Angeles, Coastal Carolina Quality Care, NexCentra Health Partners (N.C.), and USMD Physician Services (Texas – Optum)
- Depression remission at 12 months: MHN Partners (Iowa – Mercy), Emerald Coast ACO (Fla.), Keep Well ACO (Mo.), Balance ACO (N.Y.), and Empire ACO (N.Y.)
- All-cause, unplanned hospital admissions: CCACO (N.Y.), Physician Health Partners (Colo.), Paradigm ACO (Fla.), Aledade Utah ACO, Intermountain Accountable Care
- Patient satisfaction (average of eight patient experience measures): Genesis Physicians Group (Texas), Think ACO (Neb.), Aledade Louisiana ACO, South Texas ACO Clinical Partners, Northern Ohio Medical Specialists


What else you need to know
Dartmouth-Hitchcock Health and GraniteOne Health signed an agreement to combine the two health systems into one called Dartmouth-Hitchcock Health GraniteOne. They had signed a letter of intent in January; now, they’re preparing submissions to state and federal regulatory agencies for approval to merge. If the merger is approved, all organizations within the combined system will retain their existing names and local leadership, according to a joint statement released last Wednesday, and GraniteOne’s Catholic Medical Center will continue to operate under the Catholic model of care.
Walmart is testing new health benefits to help employees receive appropriate care. One, the Featured Providers program, is being piloted in select markets to help connect employees with affordable, quality physicians in their area. Walmart is partnering with Embold Health on the program; data from public and private insurers will be used to create reports on providers in eight specialties, including primary care, and Walmart will then “curate” a list of providers that have a track record of providing consistent quality care. Other benefits noted in Walmart’s news release were the Personal Healthcare Assistant — a concierge service designed to simplify the health care system — and expanded telehealth offerings that will include preventive health, chronic care management, urgent care, and behavioral health services.
The Institute for Clinical and Economic Review, better known as ICER, pulled a draft evidence report it released in late September on three new rheumatoid arthritis drugs. The drugs all belong to a new class called Janus kinase (JAK) inhibitors: AbbVie’s successor to Humira (adalimumab), Rinvoq (upadacitinib), Pfizer’s Xeljanz (tofacitinib), and Eli Lilly and Incyte’s Olumiant (baricitinib). Reviewers said in the report that Rinvoq and Xeljanz provide “marginal” clinical benefits and that not enough data are available on Olumiant to conduct an adequate cost-effectiveness analysis. Then, last Wednesday, ICER posted an update on its website stating that it had decided to re-evaluate the modeling approach used in the draft report and would be issuing a preliminary revision within several days.
UPS is set to expand its drone delivery service to hospital campuses nationwide. The company announced Tuesday that its Flight Forward subsidiary received the first-ever full Part 135 Standard certification from the Federal Aviation Administration to operate a drone airline. That certification places no limits on the size or scope of operations, UPS noted. Flight Forward has been making non-commercial drone deliveries as part of a pilot program launched in July at WakeMed Health’s hospital campus in Raleigh, N.C., but under a considerably more restrictive certification. Meanwhile, Walgreens is partnering with Alphabet subsidiary Wing to test an on-demand drone delivery service to deliver food, over-the-counter drugs, and other health and wellness products (but not prescription medications), initially to customers in Christiansburg, Va.
Civica Rx’s first drug has been administered to patients. The nonprofit generic drug company was founded a year ago by Intermountain Healthcare and half a dozen other prominent health systems to address drug shortages and high prices. On Wednesday, the company announced that patients at Riverton Hospital in Utah had been treated with Civica Rx’s vancomycin, an antibiotic that has been in short supply at thousands of U.S. hospitals, Civica Rx noted. The vancomycin, which is supplied through a partnership with Xellia Pharmaceuticals, should be available to all health systems later this month, Civica Rx said. Daptomycin, another antibiotic, will be the next drug Civica Rx delivers, followed by as many as 15 others.
Dr. Patrick Conway has stepped down as CEO of Blue Cross Blue Shield of North Carolina after recent news of his arrest in June for driving while impaired and a related charge. Gerald Petkau, who is the company’s chief operating officer, has been named interim CEO. Consequent to the change in leadership, Cambia Health Solutions issued a short statement that said the two companies have withdrawn their applications for regulatory approval for a strategic affiliation they’d announced in March. Dr. Conway had been tapped to lead the combined entity.
The White House issued an executive order Thursday directing the Department of Health and Human Services to come up with proposals to improve Medicare, with a focus on expanding plan options, improving the enrollment process, giving beneficiaries in Medicare Advantage plans better access to providers, and streamlining regulatory requirements so that providers can spend more time with patients.What we're reading
Medicaid Expansion and Health: Assessing the Evidence After 5 Years. JAMA, 9.6.19
Designing the Future of Healthcare. Journal of Healthcare Management, Sept/Oct 2019 (ACHE membership or subscription required)
130 ACOs to know - 2019. Becker’s Hospital Review, 9.20.19
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.


